125 related articles for article (PubMed ID: 17074676)
21. Improved survival trends in platinum-resistant patients with advanced ovarian, fallopian or peritoneal cancer treated with first-line paclitaxel/platinum chemotherapy: the impact of novel agents.
Bamias A; Bamia C; Zagouri F; Kostouros E; Kakoyianni K; Rodolakis A; Vlahos G; Haidopoulos D; Thomakos N; Antsaklis A; Dimopoulos MA
Oncology; 2013; 84(3):158-65. PubMed ID: 23296063
[TBL] [Abstract][Full Text] [Related]
22. [Current data concerning neoadjuvant chemotherapy].
Depierre A
Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S11-3. PubMed ID: 16719148
[No Abstract] [Full Text] [Related]
23. Long-term survival in advanced ovarian carcinoma following cytoreductive surgery with standard peritonectomy procedures.
Tentes AA; Mirelis CG; Markakidis SK; Bekiaridou KA; Bougioukas IG; Xanthoulis AI; Tsalkidou EG; Zafiropoulos GH; Nikas IH
Int J Gynecol Cancer; 2006; 16(2):490-5. PubMed ID: 16681716
[TBL] [Abstract][Full Text] [Related]
24. [Successful treatment of primary peritoneal carcinoma with paclitaxel and carboplatin combination chemotherapy].
Tohya T; Ujioka T; Yamaguchi M
Gan To Kagaku Ryoho; 2008 Jan; 35(1):153-5. PubMed ID: 18195548
[TBL] [Abstract][Full Text] [Related]
25. Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum.
Look M; Chang D; Sugarbaker PH
Int J Gynecol Cancer; 2003; 13(6):764-70. PubMed ID: 14675312
[TBL] [Abstract][Full Text] [Related]
26. Surgically documented responses to paclitaxel and cisplatin in patients with primary peritoneal carcinoma.
Menzin AW; Aikins JK; Wheeler JE; Rubin SC
Gynecol Oncol; 1996 Jul; 62(1):55-8. PubMed ID: 8690292
[TBL] [Abstract][Full Text] [Related]
27. [Clinicopathologic study on 61 cases of uterine papillary serous carcinoma with or without adjuvant therapy].
Xue DB; Ding LJ; Xia AL; Chen D; Xia HP; Teng XD; Xu ST; Zhang SJ; Ren XC
Zhonghua Bing Li Xue Za Zhi; 2010 Oct; 39(10):671-4. PubMed ID: 21176532
[TBL] [Abstract][Full Text] [Related]
28. The effect of age on first-line chemotherapy for epithelial ovarian cancer and primary peritoneal carcinoma.
Larbi E; Madhuri K; Essapen S; Butler-Manuel S; Tailor A; Michael A
Clin Oncol (R Coll Radiol); 2013 Jan; 25(1):75. PubMed ID: 23146339
[No Abstract] [Full Text] [Related]
29. Neoadjuvant chemotherapy in uterine papillary serous carcinoma.
Resnik E; Taxy JB
Gynecol Oncol; 1996 Jul; 62(1):123-7. PubMed ID: 8690284
[TBL] [Abstract][Full Text] [Related]
30. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma.
Low JS; Wong EH; Tan HS; Yap SP; Chua EJ; Sethi VK; Soh LT; Low J; Tay EH; Chew SH
Gynecol Oncol; 2005 Apr; 97(1):171-7. PubMed ID: 15790454
[TBL] [Abstract][Full Text] [Related]
32. [Nogitecan hydrochloride].
Negoro S
Nihon Rinsho; 2002 May; 60 Suppl 5():370-3. PubMed ID: 12101691
[No Abstract] [Full Text] [Related]
33. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary.
Bloss JD; Liao SY; Buller RE; Manetta A; Berman ML; McMeekin S; Bloss LP; DiSaia PJ
Gynecol Oncol; 1993 Sep; 50(3):347-51. PubMed ID: 8406199
[TBL] [Abstract][Full Text] [Related]
34. Primary papillary serous carcinoma of the peritoneum: four cases and review of computed tomography findings.
Puvaneswary M; Proietto T
Australas Radiol; 2004 Sep; 48(3):421-5. PubMed ID: 15345001
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in the management of women with ovarian cancer.
Eltabbakh GH
Minerva Ginecol; 2004 Feb; 56(1):81-9. PubMed ID: 14973412
[TBL] [Abstract][Full Text] [Related]
36. Combined chemotherapy regimen of carboplatin and paclitaxel as adjuvant treatment for papillary serous and clear cell endometrial cancer.
Shechter-Maor G; Bruchim I; Ben-Harim Z; Altaras M; Fishman A
Int J Gynecol Cancer; 2009 May; 19(4):662-4. PubMed ID: 19509567
[TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant intraperitoneal chemotherapy with paclitaxel for the radical surgical treatment of peritoneal carcinomatosis in ovarian cancer: a prospective pilot study.
Muñoz-Casares FC; Rufián S; Arjona-Sánchez Á; Rubio MJ; Díaz R; Casado Á; Naranjo Á; Díaz-Iglesias CJ; Ortega R; Muñoz-Villanueva MC; Muntané J; Aranda E
Cancer Chemother Pharmacol; 2011 Jul; 68(1):267-74. PubMed ID: 21499894
[TBL] [Abstract][Full Text] [Related]
38. Lymph node spread in stage III or IV primary peritoneal serous papillary carcinoma.
Dubernard G; Morice P; Rey A; Camatte S; Pautier P; Lhommé C; Duvillard P; Castaigne D
Gynecol Oncol; 2005 Apr; 97(1):136-41. PubMed ID: 15790449
[TBL] [Abstract][Full Text] [Related]
39. Treatment and prognostic factors in primary peritoneal carcinoma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO).
Unal OU; Oztop I; Yazici O; Ozatli T; Inal A; Günaydın Y; Alici S; Demirci U; Cinkir HY; Aktas B; Aslan K; Uncu D; Yilmaz AU; Oksuzoglu B; Buyukberber S
Oncol Res Treat; 2014; 37(6):332-8. PubMed ID: 24903764
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapy for ovarian cancer: an evidence-based approach.
Geisler JP; Manahan KJ; Wiemann MC
Minerva Ginecol; 2004 Dec; 56(6):539-45. PubMed ID: 15729206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
